XBiotech (XBIT) Announces License from CT Atlantic AG for Anti-NY-ESO-1 Antibody Targeting Advanced Cancer
Tweet Send to a Friend
XBiotech USA, Inc. (NASDAQ: XBIT) announced today that it has obtained an exclusive, worldwide license from CT Atlantic AG (CTA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE